Company registration number 13273757 (England and Wales)
BELGRAVIA HEALTHCARE LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 23 APRIL 2024
PAGES FOR FILING WITH REGISTRAR
BELGRAVIA HEALTHCARE LTD
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 6
BELGRAVIA HEALTHCARE LTD
BALANCE SHEET
AS AT
23 APRIL 2024
23 April 2024
- 1 -
23 April 2024
31 December 2022
Notes
£
£
£
£
Current assets
Debtors
4
283,205
-
0
Cash at bank and in hand
805
691
284,010
691
Creditors: amounts falling due within one year
5
(764,349)
(319,434)
Net current liabilities
(480,339)
(318,743)
Capital and reserves
Called up share capital
6
2
2
Profit and loss reserves
(480,341)
(318,745)
Total equity
(480,339)
(318,743)

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial period ended 23 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 20 January 2025 and are signed on its behalf by:
Mr T Roe
Director
Company registration number 13273757 (England and Wales)
BELGRAVIA HEALTHCARE LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 23 APRIL 2024
- 2 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 January 2022
2
(85,062)
(85,060)
Period ended 31 December 2022:
Loss and total comprehensive income
-
(233,683)
(233,683)
Balance at 31 December 2022
2
(318,745)
(318,743)
Period ended 23 April 2024:
Loss and total comprehensive income
-
(161,596)
(161,596)
Balance at 23 April 2024
2
(480,341)
(480,339)
BELGRAVIA HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 23 APRIL 2024
- 3 -
1
Accounting policies
Company information

Belgravia Healthcare Ltd is a private company limited by shares incorporated in England and Wales. The registered office is St James House, Central Park, Telford, England, TF2 9TZ.

1.1
Reporting period

The current period financial statements relate to the period from 1 January 2023 to 23 April 2024. Belgravia Capital Investments Limited ceased control of the company on 23 April 2024.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

These financial statements are prepared on the going concern basis. The directors have a reasonable expectation that the company will continue in operational existence for the foreseeable future. However, the directors are aware of certain material uncertainties which may cause doubt on the company's ability to continue as a going concern.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with bank.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

BELGRAVIA HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 23 APRIL 2024
1
Accounting policies
(Continued)
- 4 -
Basic financial liabilities

Basic financial liabilities, including creditors and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.8
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.9
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.10
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

BELGRAVIA HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 23 APRIL 2024
- 5 -
3
Employees

The average monthly number of persons (excluding directors) employed by the company during the period was:

2024
2022
Number
Number
Total
-
0
-
0
4
Debtors
2024
2022
Amounts falling due within one year:
£
£
Other debtors
283,205
-
0
5
Creditors: amounts falling due within one year
2024
2022
£
£
Trade creditors
8,593
1,042
Other creditors
755,756
318,392
764,349
319,434
6
Called up share capital
2024
2022
2024
2022
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
2
2
2
2
7
Financial commitments, guarantees and contingent liabilities

The company has provided a guarantee to Zodeq Limited as collateral to a loan facility provided to Komplex Care Limited and Komplex Community Limited, both related party by virtue of common control. A fixed and floating charge over all assets, property and undertakings of company is held by Zodeq Limited.

8
Directors' transactions

Other creditors includes an amount of £57,655 (2022: £Nil) owed to the directors. The loan is unsecured, interest free and repayable on demand.

 

BELGRAVIA HEALTHCARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 23 APRIL 2024
- 6 -
9
Related party transactions

At the balance sheet date, the company owed £570,522 (2022: £229,337) and £120,029 (2022: £86,655) Komplex Care Limited and Komplex Community Limited respectively, related parties by virtue of common control.

 

At the balance sheet date, £9,700 (2022: £Nil) and £273,505 (2022: £Nil) were owed by Rola Property Limited and Belgravia Home Healthcare LLP respectively, related parties by virtue of common control.

2024-04-232023-01-01false20 January 2025CCH SoftwareCCH Accounts Production 2024.100No description of principal activityMr T RoeMrs S P LaneMr A ZaibMr S Daviesfalsefalse132737572023-01-012024-04-23132737572024-04-23132737572022-12-3113273757core:CurrentFinancialInstrumentscore:WithinOneYear2024-04-2313273757core:CurrentFinancialInstrumentscore:WithinOneYear2022-12-3113273757core:CurrentFinancialInstruments2024-04-2313273757core:CurrentFinancialInstruments2022-12-3113273757core:ShareCapital2024-04-2313273757core:ShareCapital2022-12-3113273757core:RetainedEarningsAccumulatedLosses2024-04-2313273757core:RetainedEarningsAccumulatedLosses2022-12-3113273757core:ShareCapital2021-12-3113273757core:RetainedEarningsAccumulatedLosses2021-12-3113273757bus:Director12023-01-012024-04-2313273757core:RetainedEarningsAccumulatedLosses2022-01-012022-12-31132737572022-01-012022-12-3113273757core:RetainedEarningsAccumulatedLosses2023-01-012024-04-2313273757core:WithinOneYear2024-04-2313273757core:WithinOneYear2022-12-3113273757bus:PrivateLimitedCompanyLtd2023-01-012024-04-2313273757bus:SmallCompaniesRegimeForAccounts2023-01-012024-04-2313273757bus:FRS1022023-01-012024-04-2313273757bus:AuditExemptWithAccountantsReport2023-01-012024-04-2313273757bus:Director22023-01-012024-04-2313273757bus:Director32023-01-012024-04-2313273757bus:Director42023-01-012024-04-2313273757bus:FullAccounts2023-01-012024-04-23xbrli:purexbrli:sharesiso4217:GBP